Clinical Trial: Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Primary IgA Nephropathy
Study Type: OBSERVATIONAL
Official Title: Replication of the NefIgArd Trial of Effectiveness and Safety of a Targeted-release Formulation of Budesonide in Patients With Primary IgA Nephropathy
Brief Summary:
This replication of the NefIgArd trial of TRF-budesonide aims to use real-world data to evaluate the efficiency and safety of TRF-budesonide in the treatment of IgA nephropathy, from completing real-world research to providing real-world evidence.
Read more